Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Biocon presents key Insights into clinical study that enabled DCGI approval of Itolizumab

expresspharmaJuly 15, 2020

Tag: Biocon , Itolizumab , DCGI

PharmaSources Customer Service